SMA News & Perspectives

SMA News & Perspectives

Daily, digital coverage of the latest SMA news and perspectives.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(445)

#79: Interview With Ainaa Farhanah, a Graphic Designer Living with SMA

#79: Interview With Ainaa Farhanah, a Graphic Designer Living with SMA

In episode 79, host Kevin Schaefer talks with Ainaa Farhanah from Kuala Lumpur, Malaysia. Ainaa is a graphic designer and art teacher with SMA. She talks about growing up with SMA, family, college, an...

8 Huhti 202126min

Scholar Rock Wins US Patent for Apitegromab & Receiving The COVID-19 Vaccine And Getting Outside

Scholar Rock Wins US Patent for Apitegromab & Receiving The COVID-19 Vaccine And Getting Outside

SMA News Today’s multimedia associate, Price Wooldridge, discusses Scholar Rock winning a U.S. patent to Apitegromab for treating Spinal Muscular Atrophy (SMA). Also, Kevin Schaefer talks about retur...

7 Huhti 20217min

Zolgensma Helped Pre-symptomatic Babies Achieve Age-Appropriate Motor Milestones

Zolgensma Helped Pre-symptomatic Babies Achieve Age-Appropriate Motor Milestones

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Zolgensma helped pre-symptomatic babies with Spinal Muscular Atrophy (SMA) achieve age-appropriate motor milestones. Instagram i...

5 Huhti 202111min

Zolgensma Continues to Prevent Motor Function Decline for 5 Years

Zolgensma Continues to Prevent Motor Function Decline for 5 Years

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Zolgenzma continues to prevent motor function decline for five years for patients with Spinal Muscular Atrophy (SMA). Also, SMA ...

2 Huhti 202111min

Evrysdi Leads to Longer-term Benefits for SMA Types 2, 3, Data Show

Evrysdi Leads to Longer-term Benefits for SMA Types 2, 3, Data Show

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Evrysdi leads to longer-term benefits for Spinal Muscular Atrophy (SMA) patients, Types 2 and 3. Forums Director Kevin Schaefer ...

31 Maalis 202111min

Zolgenzma Found To Be Safe And Effective in SMA Toddlers & The Importance of Schedules And Routines

Zolgenzma Found To Be Safe And Effective in SMA Toddlers & The Importance of Schedules And Routines

SMA News Today’s multimedia associate, Price Wooldridge, discusses Zolgenzma being found safe and effective in Spinal Muscular Atrophy (SMA) toddlers. Also, DeAnn Runge welcomes new listeners and for...

29 Maalis 202110min

Evrysdi Safe in SMA Patients Previously Given Other Therapies & The Evolution of Technology

Evrysdi Safe in SMA Patients Previously Given Other Therapies & The Evolution of Technology

SMA News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Evrysdi is safe in Spinal Muscular Atrophy (SMA) patients previously given other therapies. DeAnn Runge talks abo...

26 Maalis 20219min

SMA Foundation and PTC Joint Efforts to Fund Regenerative Medicine Research

SMA Foundation and PTC Joint Efforts to Fund Regenerative Medicine Research

SMA News Today’s multimedia associate, Price Wooldridge, discusses the SMA Foundation and PTC Therapeutics joint efforts to fund regenerative medicine research. Also, Forums Director Kevin Schaefer s...

24 Maalis 20216min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
tiedenaiset-podcast
meditaatiot-suomeksi
voi-hyvin-meditaatiot-2
rss-pitaisko-erota
rss-seksicast
selviytyjat-tarinoita-elamasta
rss-kuumilla-aalloilla
terapiassa
rss-pt-paahtio
rss-mighty-finland-podcast
katilon-kahvitunti
paritellen
aamukahvilla
junnut-pelissa
rss-perho-rajoilla
traumapodi
mielipaivakirja